Free shipping on all orders over $ 500

Dihydroergotamine mesylate

Cat. No. M13868

All AbMole products are for research use only, cannot be used for human consumption.

Dihydroergotamine mesylate Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Dihydroergotamine mesylate is an ergot alkaloid used to treat migraines. Target: 5-HT Receptors Dihydroergotamine is not as effective as sumatriptan or phenothiazines as a single agent for treatment of acute migraine headache; however, when administered with an antiemetic, dihydroergotamine appears to be as effective as opiates, ketorolac, or valproate. Given its nonnarcotic properties, parenteral dihydroergotamine combined with an antiemetic should be considered as effective initial therapy in clinical practice. The introduction of the intranasal formulation of DHE provides both pharmacologic and patient-convenience advantages for use in migraine therapy [2, 3].

Chemical Information
Molecular Weight 679.78
CAS Number 6190-39-2
Solubility (25°C) DMSO 50 mg/mL
Storage 2-8°C, protect from light, dry, sealed
References

[1] Rasha Srouji, et al. Headache. Dihydroergotamine infusion for pediatric refractory headache: A retrospective chart review

[2] Stephen Silberstein. Expert Opin Pharmacother. MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine

[3] John A Morren, et al. Expert Opin Pharmacother. Where is dihydroergotamine mesylate in the changing landscape of migraine therapy?

[4] R B Lipton. Headache. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles

[5] J A Barone, et al. Pharmacotherapy. Combination dihydroergotamine mesylate and heparin sodium with lidocaine HCl. Pharmacokinetics, mechanism of action, clinical efficacy, and adverse effects

Related 5-HT Receptor Products
Tegaserod

Tegaserod is an orally active serotonin receptor 4 (5-HT4R) agonist and a 5-HT2B receptor antagonist. Tegaserod has pKis of 7.5, 8.4 and 7.0 for human recombinant 5-HT2A, 5-HT2B and 5-HT2C receptors, respectively. Tegaserod causes tumor cell apoptosis, blunts PI3K/Akt/mTOR signaling and decreases S6 phosphorylation.

cis-Urocanic acid

cis-Urocanic acid is a 5-HT2A receptor agonist. cis-Urocanic acid binds to 5-HT receptor with relatively high affinity (Kd=4.6 nM). cis-Urocanic acid is also an immune modulator that induces immunosuppression.

5-HT2B antagonist-1

5-HT2B antagonist-1 is an orally active 5-HT2B receptor antagonist with an IC50 value of 33.4 nM.

AS19 

AS19 is a potent, selective 5-HT7 receptor agonist with an IC50 value of 0.83 nM and a Ki of 0.6 nM.

CP94253 

CP94253 is a selective, orally active agonist for serotonin receptor 1B (5-HT1B), through competitive binding with iodocyanopindolol (ICP) to the 5-HT1 receptor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Dihydroergotamine mesylate supplier, 5-HT Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.